🇺🇸 FDA

Intelligence Platform

Patents

Browse 37 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9974793

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9913909

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9913910

Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising g

Heron Therapeutics, Inc. · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808465

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801945

Long-acting polymeric delivery systems

Heron Therapeutics, Inc. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9744163

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9694079

Long-acting polymeric delivery systems

Heron Therapeutics, Inc. · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592227

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9561229

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446036

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315568

Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders

ADHERON THERAPEUTICS, INC. · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940300

Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and

ADHERON THERAPEUTICS, INC. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8715710

Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

Heron Therapeutics, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted